Brief: Rafael Holdings Announces Strategic Merger With Rafael Pharmaceuticals To Form A Focused Late-Stage Clinical Oncology Company

Rafael Holdings

21/06/2021 12:41

June 21 (Reuters) - Rafael Holdings Inc  RFL.N :
    * RAFAEL HOLDINGS ANNOUNCES STRATEGIC MERGER WITH RAFAEL
PHARMACEUTICALS TO FORM A FOCUSED LATE-STAGE CLINICAL ONCOLOGY
COMPANY
    * RAFAEL HOLDINGS - WILL ACQUIRE FOR $30 MILLION REMAINING
MEMBERSHIP INTEREST IN ALTIRA CAPITAL & CONSULTING, LLC THAT IT
DOES NOT ALREADY OWN
    * RAFAEL HOLDINGS INC - MERGED COMPANY WILL RETAIN RAFAEL
PHARMACEUTICALS NAME AND RAFAEL HOLDINGS' LISTING ON NEW YORK
STOCK EXCHANGE
    * RAFAEL HOLDINGS - CO, UNITS CURRENTLY OWN A MAJORITY OF
OUTSTANDING STOCK OF RAFAEL PHARMACEUTICALS AND A SIGNIFICANT
STAKE ON A FULLY-DILUTED BASIS
    * RAFAEL HOLDINGS INC - HOWARD JONAS WILL SERVE AS CHAIRMAN,
AMEET
MALLIK WILL SERVE AS CEO
    * RAFAEL HOLDINGS - HOLDERS OF RAFAEL PHARMA CAPITAL STOCK
TO GET
SHARES OF CO'S CLASS B STOCK AMOUNTING TO ABOUT 48% OF
OUTSTANDING CAPITALIZATION OF CO
    * RAFAEL HOLDINGS - WILL CONSUMMATE A CAPITAL RAISE OF AT
LEAST
$50 MILLION LESS POTENTIAL PROCEEDS FROM SALE OF CERTAIN REAL
ESTATE ASSETS

Source text for Eikon:  ID:nPn943Qd8a 
Further company coverage:  RFL.N 

 ((reuters.briefs@thomsonreuters.com;))